Augmented reality helps surgeons, students see a bigger picture

Leica Microsystems, developers of microscopes capable of viewing microstructures and nanostructures, has introduced its augmented reality imaging technologies for surgical microscopes at the American Association of Neurological Surgeons (AANS) Annual Scientific Meeting 2017.

The GLOW800 supports surgeons in making decisions and teaching students on complex neurosurgical procedures. GLOW800 augmented reality fluorescence was developed to improve vascular fluorescence during neurosurgery. The augmented reality combines the high contrast of near infrared fluorescence imaging with white light into a single image, allowing surgeons to view one image with both white light and colored images in real-time.

This comprehensive view of the anatomy allow for less interruptions and more advanced decision making.

"Leica Microsystems is and always has been committed to developing innovative new ways to support its customer's needs and requirements. In delicate neurosurgery the outstanding optical quality provided by our microscopes is not always enough. This customer paint point motivated us to develop innovative new ways to augment surgical visualization so that surgeons can operate with as much knowledge and confidence as possible," said Markus Lusser, president of Leica Microsystems. "Moreover, we ensure these new augmented technologies can be fully integrated into our premium neurosurgical microscope at any time. This gives surgeons and hospitals complete flexibility, protects their investment, and helps them remain at the cutting edge when we introduce the next advance in augmented reality imaging."

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.